Poster Presentations: Wednesday, October 26, 2011 |

Impact of a CT Bronchus Sign in the Diagnosis of Peripheral Lung Nodules With Peripheral/Radial Endobronchial Ultrasound Guided Transbronchial Biopsy FREE TO VIEW

David Hsia, MD; Kurt Jensen, MD; Ali Musani, MD
Chest. 2011;140(4_MeetingAbstracts):472A. doi:10.1378/chest.1117620
Text Size: A A A
Published online


PURPOSE: Pulmonary nodules are frequently encountered in clinical practice. Sensitivity of traditional bronchoscopy and fluoroscopic transbronchial biopsy is only 34% for nodules <2 cm and 63% for lesions >2 cm in size in malignant disease (1), and is likely less for non-malignant etiologies. Navigational bronchoscopy technologies, such as radial ultrasound (RU), have increased yields for diagnosing peripheral malignancies (2). Presence of a CT bronchus sign has also been reported to increase yields to 79% with electromagnetic navigation bronchoscopy (EMN) (3). We examine the impact of the bronchus sign with RU bronchoscopy for diagnosing peripheral lung nodules.

METHODS: Retrospective review of 40 consecutive patients with RU-guided transbronchial biopsy of lung nodules ≤3 cm was performed. The RU probe was passed through a guide-sheath catheter which served as an extended working channel for biopsy instruments after the probe was removed. Fluoroscopy was used to ensure stable guide-sheath positioning between multiple biopsies. Malignancy was determined by bronchoscopic or subsequent diagnostic procedure. Lesions were considered benign if an alternative non-malignant pathology was established with bronchoscopic RU-guided biopsy or on subsequent surgical resection or ≥6 month radiographic stability or regression.

RESULTS: Mean patient age was 64.8±11.4 (SD) years with an average of 27.9±31.5 (SD) pack years of tobacco use. Mean nodule size was 2.04±0.60 (SD) cm. 42.5% (17/40) of the nodules were malignant and 42.5% (17/40) were benign. Follow-up data was not available for 15% (7/40) of cases. Sensitivity of RU navigational bronchoscopy was 65.0% (26/40) with a sensitivity of 70.6% (12/17) in malignant cases. A CT “bronchus sign” was present in 70.6% (12/17) of malignant cases, and sensitivity of RU-guided bronchoscopy with a “bronchus sign” was 83.3% (10/12) compared to 40.0% (2/5) without.

CONCLUSIONS: For malignant pulmonary nodules, RU-guided transbronchial biopsy can provide a diagnostic yield similar to EMN bronchoscopy.

CLINICAL IMPLICATIONS: RU provides real-time radiographic confirmation of accurate localization of peripheral lung lesions without pre-procedure virtual planning time or expense of the disposable steerable guide required in EMN bronchoscopy.

DISCLOSURE: The following authors have nothing to disclose: David Hsia, Kurt Jensen, Ali Musani

No Product/Research Disclosure Information

09:00 AM - 10:00 AM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543